PIWIL4 and cancer: In MDA-MB-231 cells derived from triple-negative breast cancer, PIWIL4 was reported to be able to upregulate the TGF-β, MAPK/ERK, and FGF pathways, which resulted in increased migration, proliferation, and survival of cancer cells [53].